GE HealthCare Technologies Inc. Common Stock vs Walmart Stores Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while Walmart Stores Inc trades at $119.42 (market cap $921.58B). The key difference: Walmart Stores Inc is far larger — about 29.8× GE HealthCare Technologies Inc. Common Stock's market cap, and Walmart Stores Inc pays the higher dividend (0.85%). Which is the better fit depends on your goals.
| GEHC | WMT | |
|---|---|---|
Market Cap | $30.93B | $921.58B |
Volume | 5,033,451 | 25,862,870 |
Sector | Health | Consumer Staples |
52-Week High | $88.16 | $134.20 |
52-Week Low | $59.48 | $100.61 |
Enterprise Value | $39.39B | $983.81B |
Dividend Yield | 0.23% | 0.85% |
Typical Hold Time | — | 101 Days |
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Walmart (WMT) trades at $112.28, down 0.71% on the day, with a bullish technical signal from moving averages but overbought short-term RSI. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $0.81 exceeding the $0.742 estimate. Revenue growth is robust, reaching $681.0B in 2025, and analyst sentiment is overwhelmingly positive with a 71.21% buy rating. Recent news highlights expansion in AI capabilities, Marketplace growth over 50%, and a new Medicare Advantage partnership.
The outlook for WMT remains favorable driven by digital growth and market share gains, though valuation multiples like a P/E of 40.68 pose a risk if execution falters. Key opportunities include e-commerce expansion and cost efficiencies, while risks involve inflationary pressures and rising capital expenditures. The consensus price target of $128.84 suggests ~15% upside from current levels.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →Walmart Inc. operates discount stores, supercenters, and neighborhood markets. The Company offers merchandise such as apparel, house wares, small appliances, electronics, musical instruments, books, home improvement, shoes, jewelry, toddler, games, household essentials, pets, pharmaceutical products, party supplies, and automotive tools. Walmart serves customers worldwide.
Read more on WMT →